Article
Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients.
Human mutation - 1 Oct 2012
Abicht Angela, Dusl Marina, Gallenmüller Constanze, Guergueltcheva Velina, Schara Ulrike, Della Marina Adele, Wibbeler Eva, Almaras Sybille, Mihaylova Violeta, von der Hagen Maja, Huebner Angela, Chaouch Amina, Müller Juliane S, Lochmüller Hanns
Abstract excerpt
Congenital myasthenic syndromes (CMSs) are clinically and genetically heterogeneous disorders characterized by a neuromuscular transmission defect. Even though CMSs are genetic disorders, they are highly treatable, and the appropriate drug treatment depends on the underlying genetic defect. This highlights the importance of genetic testing in CMS. In recent years, the molecular basis of CMS has constantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
